title: Effects of amlodipine and candesartan on oxidized LDL level in patients with mild to moderate essential hypertension.
abstract: OBJECTIVE
  To compare the effects of amlodipine and candesartan on oxidized low-density lipoprotein (OxLDL), conjugated dienes (CD) and baseline diene conjugation in circulating low-density lipoproteins (LDL-BDC) level during antihypertensive treatment.
  
  
  METHODS
  Forty-nine patients with untreated mild to moderate essential hypertension were recruited in a randomized double-blind study to receive a daily dose either of 8 mg candesartan or 5 mg amlodipine for 16 weeks. Blood pressure, OxLDL, CD, LDL-BDC, triglycerides (TG), total cholesterol and lipoprotein cholesterol were measured at baseline, at week 2 and at week 16.
  
  
  RESULTS
  During treatment, in addition to a significant decrease in systolic and diastolic blood pressure, high level of OxLDL decreased significantly reaching practically upper kit reference values. Both treatment groups were similar with regard to the studied parameters at all time points. At the same time serum TG, lipoprotein and total cholesterol levels as well as LDL-BDC did not change and CD levels did not exceed endemic normal. Decrease in both systolic and diastolic blood pressure was associated with decrease in LDL-BDC/LDL.
  
  
  CONCLUSIONS
  Besides their antihypertensive effects, both candesartan and amlodipine are efficient drugs for reducing OxLDL level, being neutral with regard to serum lipids.
authors: Department of Cardiology, University of Tartu, L.Puusepa 8, Tartu 51014, Estonia. piibe.muda@kliinikum.ee
authors: Piibe
authors: P
authors: Muda
authors: Priit
authors: P
authors: Kampus
authors: Rein
authors: R
authors: Teesalu
authors: Kersti
authors: K
authors: Zilmer
authors: Tiina
authors: T
authors: Ristimäe
authors: Krista
authors: K
authors: Fischer
authors: Mihkel
authors: M
authors: Zilmer
mesh_terms: D000475:Alkenes; D017311:Amlodipine / Q000008:administration & dosage / Q000494:pharmacology*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000494:pharmacology*; D001713:Biphenyl Compounds; D001794:Blood Pressure / Q000187:drug effects; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008077:Lipoproteins, LDL / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D013777:Tetrazoles / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D000475:Alkenes; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D008055:Lipids; D008077:Lipoproteins, LDL; D013777:Tetrazoles; C099252:oxidized low density lipoprotein; D017311:Amlodipine; C081643:candesartan